Menu
Washingtoner
  • Home
  • Health
  • Business
  • Books
  • Lifestyle
  • Aerospace
  • Technology
  • Legal
  • Financial
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • The Problem With AI Isn't Compute. It's Memory
  • ATTENTION: DGCA India & CAAC China — Boeing Quality Chief Doug Ackerman Linked To 24 Year Unaccredited Manufacturing Gap Ahead Of 787 Failures
  • SPD Investigate Homicide In North Spokane - One Male In Custody
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Brilliant Minds to Gather in Fort Worth for National Mensa Event
  • UK Financial Ltd Completes One Of The Most Extensive CoinMarketCap Supply Verification Packages For Maya Preferred PRA (MPRA)
  • Data Tiles Strengthens U.S. Presence with Chief Revenue Officer John Goode
  • Haven Media Solutions Offers Web Design and PPC Services in Atlanta GA
  • Spokane: 2026 Pools & Aquatics Information

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Spokane: Council Members Introduce An Ordinance Imposing Data Center Moratorium
  • The $5 Million Man Still Begging: Incumbent Jimmy Panetta Hits Up Voters for More Cash Despite Massive War Chest
  • Kevin Francis Design Introduces CHROMA, a Collection of Saturated Solid Color Wool Rugs
  • $150+ Million Contracted Backlog, Strategic Acquisitions Adding Millions In Recurring Revenue, Improving Margins & A Clear Path Toward Profitability
  • Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc
  • Bergey's Truck Centers Recognized in 2026 MACH Alliance Composable Impact Awards
  • Tacoma: City Council Adopts Updated Stormwater Management Manual to Enhance Environmental Health and Regulatory Compliance
  • Spokane Police Sergeant Pulls Elderly Female from Burning Home
  • What Would you Do with Your Time if it Was Actually Money?
  • Mr. Hospital Bed Showcases the Best Hospital Bed and Air Mattress for Bed Sores for 2026
  • City of Tacoma Presents Updated Financial Forecast as Next Step in 'Roadmap to Recovery' to Navigate National Economic Pressures
  • Tacoma: Full Intersection Closure at E. 11th Street and St. Paul Avenue for One-Day Asphalt Repairs on June 27
  • Spokane: Early-Morning House Fire Damages Two Homes on East Sanson Avenue
  • Spokane City Council Passes Aggressive Speeding Ordinance
  • Traian TKD Tractari Auto Iasi: cum transporti legal la RAR o masina fara numere sau cu ITP expirat
  • Republican National Hispanic Assembly & Metropolitan Republican Club Announce Strategic Partnership
  • Lake East Landscape Highlights Full-Service Landscaping Solutions Across Seattle and Nearby Areas
  • Proactive Tax & Advisory and Accountability Services Merge and Rebrand as Proactive Advisory Group
  • Mike Williams Golf Center Now Open at Georgia's Lanier Islands Resort
  • Appliance EMT Launches June "Summer Rescue" Promotion
_catLbl0 _catLbl1

Popular on Washingtoner

  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan - 255
  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
  • Spokane: Flags Lowered for Peace Officers Memorial Day
  • The Simplest Small Business You're Probably Not Thinking About
  • iatroX surpasses 500,000 clinical queries and expands specialist exam coverage
  • All About Technology Celebrates 25 Years of Bridging Detroit's Digital Divide
  • Joseph Nybyk aka Neibich of Gilbert, Arizona
  • Lumetra Launches Engram, an MCP-Native Memory Layer Scoring 91.6% on LongMemEval
  • Spokane: Coffee Connect With District 1 Council Members
  • Inside-Out Hollywood: The Relentless Rise of Joseph Nybyk (AKA Joseph Neibich)

Similar on Washingtoner

  • CCHR Condemns Behavioral Treatment After FDA's Missed Deadline to Ban Shock Device
  • Keynote Speaker announced for the 2026 NCIHC Language Access Congress
  • Expanding Access to Mental Health Care in Toronto with Dr. Stephen Shainbart
  • Dr. Stephen Shainbart Launches Expanded Mental Health Support for Anxiety and Depression in Toronto
  • Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc
  • Mr. Hospital Bed Showcases the Best Hospital Bed and Air Mattress for Bed Sores for 2026
  • Appliance EMT Launches June "Summer Rescue" Promotion
  • Longevityresearch.ca Unveils a Unique Bayesian Causal Atlas; Saves up to 7.9 life years/patient
  • School Dental Screening Programs Conducted in Dubai
  • CCHR Calls Out Psychiatry's Pattern of Resistance to Antidepressant Deprescribing
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute